Präzisionsmedizin durch intentionale Wissenschaft
We translate the scientific potential of cannabinoids into verifiable pharmaceutical standards. By combining international pioneering work with integrated research and quality processes, we create the foundation for reproducible cannabinoid-based precision medicine.
Auf den Schultern von Giganten
Our work is consistently grounded in the foundations of modern cannabinoid research, particularly the pioneering work of Prof. Dr. Raphael Mechoulam (endocannabinoid system) and Prof. Dr. Ethan Russo (entourage concept). We see this foundation as our mission: translating findings into standards, protocols, and quality assurance.
Von der Spekulation zur Substanz
In a market often characterized by claims, we rely on a structured, transparent process. For us, "intentional science" means:
- Zielgerichtete Entwicklung: Targeted development: Focus on defined indications and clinical questions instead of broad-spectrum application.
- ReproduzierbarkeitReproducibility: Standardization of active ingredient and excipient profiles via genetic, process, and quality parameters.
- Pharmazeutische QualitätPharmaceutical quality: Development of dosage forms and protocols with the goal of precise dosing and improved bioavailability – documented and compliant with regulations.
Rückkopplung für Qualität und Evidenz:
Der „Closed-Loop“-Ansatz
Our research doesn't end in the lab. Through structured evidence and quality processes from real-world healthcare settings, we gain insights for hypothesis generation, protocol development, and standardization. The use of relevant data is GDPR-compliant, purpose-bound, and governance-supported (e.g., role/rights concepts, documentation, consent/ethical frameworks depending on the project).
Ein vernetztes System
Switzerland – Origin & Translation:
In our Swiss structures, preclinical findings are evaluated, specifications are derived, and the foundations for reproducible quality are defined (including genetics/process know-how, translation).
Germany – Validation & Development:
In Germany, specifications are translated into development and evidence processes, including study/cooperation formats, galenics and quality development.
Research Focus Areas (The Pipeline)
We concentrate our activities on complex, chronic care areas where standardized approaches and robust evidence processes are particularly relevant, such as:
- Pain medicine / interdisciplinary care
- Neurology
- Oncology (supportive care)
- Sleep/stress-related symptoms
Quick access
Legal pages
Medi First
